Patent 10449374 was granted and assigned to BlueWind Medical on October, 2019 by the United States Patent and Trademark Office.
An electrostimulator implant comprises (i) an implant body, the implant being injectable into tissue of a subject along a longitudinal axis of the implant body, (ii) first and second electrodes, disposed on respective first and second portions of the implant body; (iii) circuitry, disposed inside the implant body, and configured to drive the electrodes to apply current to the tissue; and (iv) a mesh. The mesh is configured to serve as an anchor of the implant, is disposed over a third portion of the implant body that is longitudinally between the first and second portions of the implant body, and has a first end and a second end. Each of the ends is fixedly attached to respective first and second sites of the implant body, the respective sites being longitudinally between the first and second electrodes.